DOI QR코드

DOI QR Code

Intrawound Vancomycin Powder Application for Preventing Surgical Site Infection Following Cranioplasty

  • Seong Bin Youn (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Gyojun Hwang (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Hyun-Gon Kim (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Jae Seong Kang (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Hyung Cheol Kim (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Sung Han Oh (Department of Neurosurgery, Bundang Jesaeng General Hospital, Daejin Medical Center) ;
  • Mi-Kyung Kim (Department of Neurosurgery, Myongji St Mary's Hospital) ;
  • Bong Sub Chung (Department of Neurosurgery, Anyang Sam Hospital) ;
  • Jong Kook Rhim (Department of Neurosurgery, Jeju National University Hospital) ;
  • Seung Hun Sheen (Department of Neurosurgery, Bundang CHA Medical Center, CHA University)
  • Received : 2023.01.30
  • Accepted : 2023.04.04
  • Published : 2023.09.01

Abstract

Objective : Surgical site infection is the most detrimental complication following cranioplasty. In other surgical fields, intrawound vancomycin powder application has been introduced to prevent surgical site infection and is widely used based on results in multiple studies. This study evaluated the effect of intrawound vancomycin powder in cranioplasty compared with the conventional method without topical antibiotics. Methods : This retrospective study included 580 patients with skull defects who underwent cranioplasty between August 1, 1998 and December 31, 2021. The conventional method was used in 475 (81.9%; conventional group) and vancomycin powder (1 g) was applied on the dura mater and bone flap in 105 patients (18.1%; vancomycin powder group). Surgical site infection was defined as infection of the incision, organ, or space that occurred after cranioplasty. Surgical site infection within 1-year surveillance period was compared between the conventional and vancomycin powder groups with logistic regression analysis. Penalized likelihood estimation method was used in logistic regression to deal with zero events. All local and systemic adverse events associated with topical vancomycin application were also evaluated. Results : Surgical site infection occurred in 31 patients (5.3%) and all were observed in the conventional group. The median time between cranioplasty and detection of surgical site infection was 13 days (range, 4-333). Staphylococci were the most common organisms and identified in 25 (80.6%) of 31 cases with surgical site infections. The surgical site infection rate in the vancomycin powder group (0/105, 0.0%) was significantly lower than that in the conventional group (31/475, 6.5%; crude odds ratio [OR], 0.067; 95% confidence interval [CI], 0.006-0.762; adjusted OR, 0.068; 95% CI, 0.006-0.731; p=0.026). No adverse events associated with intrawound vancomycin powder were observed during the follow-up. Conclusion : Intrawound vancomycin powder effectively prevented surgical site infections following cranioplasty without local or systemic adverse events. Our results suggest that intrawound vancomycin powder is an effective and safe strategy for patients undergoing cranioplasty.

Keywords

References

  1. Abode-Iyamah KO, Chiang HY, Winslow N, Park B, Zanaty M, Dlouhy BJ, et al. : Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty. J Neurosurg 128 : 1241-1249, 2018 https://doi.org/10.3171/2016.12.JNS161967
  2. Bader ER, Kobets AJ, Ammar A, Goodrich JT : Factors predicting complications following cranioplasty. J Craniomaxillofac Surg 50 : 134-139, 2022 https://doi.org/10.1016/j.jcms.2021.08.001
  3. Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. : Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152 : 784-791, 2017 https://doi.org/10.1001/jamasurg.2017.0904
  4. Coulter IC, Pesic-Smith JD, Cato-Addison WB, Khan SA, Thompson D, Jenkins AJ, et al. : Routine but risky: a multi-centre analysis of the outcomes of cranioplasty in the Northeast of England. Acta Neurochir (Wien) 156 : 1361-1368, 2014 https://doi.org/10.1007/s00701-014-2081-1
  5. Devin CJ, Chotai S, McGirt MJ, Vaccaro AR, Youssef JA, Orndorff DG, et al. : Intrawound vancomycin decreases the risk of surgical site infection after posterior spine surgery: a multicenter analysis. Spine (Phila Pa 1976) 43 : 65-71, 2018 https://doi.org/10.1097/BRS.0000000000001371
  6. Dial BL, Lampley AJ, Green CL, Hallows R : Intrawound vancomycin powder in primary total hip arthroplasty increases rate of sterile wound complications. Hip Pelvis 30 : 37-44, 2018 https://doi.org/10.5371/hp.2018.30.1.37
  7. Donovan TJ, Sino S, Paraforos A, Leick J, Friedrich I : Topical vancomycin reduces the incidence of deep sternal wound complications after sternotomy. Ann Thorac Surg 114 : 511-518, 2022 https://doi.org/10.1016/j.athoracsur.2021.09.036
  8. Ghobrial GM, Cadotte DW, Williams K Jr, Fehlings MG, Harrop JS : Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review. Neurosurg Focus 39 : E11, 2015
  9. Goedemans T, Verbaan D, van der Veer O, Bot M, Post R, Hoogmoed J, et al. : Complications in cranioplasty after decompressive craniectomy: timing of the intervention. J Neurol 267 : 1312-1320, 2020 https://doi.org/10.1007/s00415-020-09695-6
  10. Haimoto S, Schar RT, Nishimura Y, Hara M, Wakabayashi T, Ginsberg HJ : Reduction in surgical site infection with suprafascial intrawound application of vancomycin powder in instrumented posterior spinal fusion: a retrospective case-control study. J Neurosurg Spine 29 : 193-198, 2018 https://doi.org/10.3171/2017.12.SPINE17997
  11. Hanada M, Nishikino S, Hotta K, Furuhashi H, Hoshino H, Matsuyama Y : Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties. Knee Surg Sports Traumatol Arthrosc 27 : 2322-2327, 2019 https://doi.org/10.1007/s00167-019-05498-z
  12. Honeybul S, Ho KM : Cranioplasty: morbidity and failure. Br J Neurosurg 30 : 523-528, 2016 https://doi.org/10.1080/02688697.2016.1187259
  13. Im SH, Jang DK, Han YM, Kim JT, Chung DS, Park YS : Long-term incidence and predicting factors of cranioplasty infection after decompressive craniectomy. J Korean Neurosurg Soc 52 : 396-403, 2012 https://doi.org/10.3340/jkns.2012.52.4.396
  14. Jeong TS, Yee GT : Prospective multicenter surveillance study of surgical site infection after intracranial procedures in Korea : a preliminary study. J Korean Neurosurg Soc 61 : 645-652, 2018 https://doi.org/10.3340/jkns.2018.0021
  15. Kim JS, Park IS, Kim SK, Park H, Kang DH, Lee CH, et al. : Analysis of the risk factors affecting the surgical site infection after cranioplasty following decompressive craniectomy. Korean J Neurotrauma 11 : 100-105, 2015 https://doi.org/10.13004/kjnt.2015.11.2.100
  16. Kim YM, Park T, Lee SP, Baek JW, Ryou KS, Kim SH : Optimal timing and complications of cranioplasty: a single-center retrospective review of 109 cases. J Neurointensive Care 3 : 48-57, 2020 https://doi.org/10.32587/jnic.2020.00290
  17. Major Extremity Trauma Research Consortium (METRC); O'Toole RV, Joshi M, Carlini AR, Murray CK, Allen LE, et al. : Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. JAMA Surg 156 : e207259, 2021
  18. Molinari RW, Khera OA, Molinari WJ 3rd : Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. Eur Spine J 21 Suppl 4 : S476-S482, 2012 https://doi.org/10.1007/s00586-011-2104-z
  19. Morton RP, Abecassis IJ, Hanson JF, Barber J, Nerva JD, Emerson SN, et al. : Predictors of infection after 754 cranioplasty operations and the value of intraoperative cultures for cryopreserved bone flaps. J Neurosurg 125 : 766-770, 2016 https://doi.org/10.3171/2015.8.JNS151390
  20. National Healthcare Safety Network, Center for Disease Control and Prevention : Surgical Site Infection (SSI) Event. Available at : https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
  21. Patel NN, Guild GN 3rd, Kumar AR : Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection. Arthroplast Today 4 : 479-483, 2018 https://doi.org/10.1016/j.artd.2018.07.011
  22. Ravikumar V, Ho AL, Pendhakar AV, Sussman ES, Kwong-Hon Chow K, Li G : The use of vancomycin powder for surgical prophylaxis following craniotomy. Neurosurgery 80 : 754-758, 2017 https://doi.org/10.1093/neuros/nyw127
  23. Riordan MA, Simpson VM, Hall WA : Analysis of factors contributing to infections after cranioplasty: a single-institution retrospective chart review. World Neurosurg 87 : 207-213, 2016 https://doi.org/10.1016/j.wneu.2015.11.070
  24. Saleh A, Thabet A, Belkhair S : Topical vancomycin for prevention of surgical site infection after craniotomy: meta-analysis and systematic literature review. World Neurosurg 158 : e605-e611, 2022 https://doi.org/10.1016/j.wneu.2021.11.018
  25. Shah SJ, Jadhav UE : Efficacy of topical vancomycin application in cardiac surgery to reduce deep sternal wound infection: a randomised control trial at tertiary cardiac care hospital. Int Surg J 9 : 601-605, 2022 https://doi.org/10.18203/2349-2902.isj20220628
  26. Shibahashi K, Hoda H, Takasu Y, Hanakawa K, Ide T, Hamabe Y : Cranioplasty outcomes and analysis of the factors influencing surgical site infection: a retrospective review of more than 10 years of institutional experience. World Neurosurg 101 : 20-25, 2017 https://doi.org/10.1016/j.wneu.2017.01.106
  27. Sundseth J, Sundseth A, Berg-Johnsen J, Sorteberg W, Lindegaard KF : Cranioplasty with autologous cryopreserved bone after decompressive craniectomy: complications and risk factors for developing surgical site infection. Acta Neurochir (Wien) 156 : 805-811; discussion 811, 2014 https://doi.org/10.1007/s00701-013-1992-6
  28. Ushirozako H, Hasegawa T, Yamato Y, Yoshida G, Yasuda T, Banno T, et al. : Impact of intrawound vancomycin powder on prevention of surgical site infection after posterior spinal surgery. J Neurosurg Spine 34 : 656-664, 2021 https://doi.org/10.3171/2020.8.SPINE20992
  29. Zanaty M, Chalouhi N, Starke RM, Chitale R, Hann S, Bovenzi CD, et al. : Predictors of infections following cranioplasty: a retrospective review of a large single center study. ScientificWorldJournal 2014 : 356042, 2014
  30. Zanaty M, Chalouhi N, Starke RM, Clark SW, Bovenzi CD, Saigh M, et al. : Complications following cranioplasty: incidence and predictors in 348 cases. J Neurosurg 123 : 182-188, 2015 https://doi.org/10.3171/2014.9.JNS14405